Elmar Schnee, Director at Jazz Pharmaceuticals plc (JAZZ), sold 2,393 shares at $142.36 ($341K) on 2017-08-11, disclosed to the SEC on 2017-08-14.
Seasonal sale ($341k) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.36 | 1,194 | $170K | 49.9% |
| 2 | $142.36 | 1,194 | $170K | 49.9% |
| 3 | $144.13 | 2 | $288 | 0.1% |
| 4 | $144.20 | 3 | $433 | 0.1% |
| Total | $142.36 avg | 2,393 | $341K | 100% |
| Filing → |
| JAZZ | SELL | 2018-08-13 | $262K | — | Filing → |